{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:13:05Z","timestamp":1793110385681,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116084","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:25:13Z","timestamp":1709396713000},"page":"116084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["NPS\u2013EQA PART I: Four years\u2019 experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in oral fluid"],"prefix":"10.1016","volume":"243","author":[{"given":"Emilia","family":"Marchei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Var\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Minutillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116084_bib1","unstructured":"European Monitoring Centre for Drug and Drug Addiction European Drug Report 2020. Trends and Development. Available online: \u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13236\/TDAT20001ENN_web.pdf\u3009, 2024 (accessed 08 January 2024)."},{"key":"10.1016\/j.jpba.2024.116084_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320967197","article-title":"New psychoactive substances: a review and updates","volume":"10","author":"Shafi","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.116084_bib3","first-page":"144","article-title":"The complex and constantly evolving public health threat of new psychoactive substances in Italy: addressing the main functions of a national observatory of drugs","volume":"57","author":"Graziano","year":"2021","journal-title":"Ann. Ist. Super."},{"key":"10.1016\/j.jpba.2024.116084_bib4","first-page":"580","article-title":"New psychoactive substances and suicidality: a systematic review of the current literature","volume":"57","author":"Chiappini","year":"2021","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.jpba.2024.116084_bib5","unstructured":"United Nations Office on Drugs and Crime (UNODC). Use of the dark web and social media for drug supply. Available online \u3008https:\/\/www.unodc.org\/res\/WDR-2023\/WDR23_B3_CH7_darkweb.pdf\u3009, 2024 (Accessed 8 January 2024)."},{"key":"10.1016\/j.jpba.2024.116084_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.584462","article-title":"Consequences of covid-19 lockdown on the misuse and marketing of addictive substances and new psychoactive substances","volume":"11","author":"Di Trana","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2024.116084_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpba.2018.10.011","article-title":"methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices","volume":"163","author":"Graziano","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1-3","key":"10.1016\/j.jpba.2024.116084_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.forsciint.2012.04.003","article-title":"Evaluation of four oral fluid devices (DDS\u00ae, Drugtest 5000\u00ae, Drugwipe 5+\u00ae and RapidSTAT\u00ae) for on-site monitoring drugged driving in comparison with UHPLC-MS\/MS analysis","volume":"221","author":"Strano-Rossi","year":"2012","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.jpba.2024.116084_bib9","doi-asserted-by":"crossref","first-page":"1033733","DOI":"10.3389\/ftox.2022.1033733","article-title":"Fatal cases involving new psychoactive substances and trends in analytical techniques","volume":"4","author":"Ferrari J\u00fanior","year":"2022","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.14236","article-title":"The challenge of the novel psychoactive substances: how have we responded and what are the implications of this response?","volume":"86","author":"Wood","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.116084_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1515\/pac-2017-0605","article-title":"The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)","volume":"90","author":"Abbate","year":"2018","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.jpba.2024.116084_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","volume":"131","author":"Axelsson","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2174\/1570159X1709190729101751","article-title":"New psychoactive substances: a matter of time","volume":"17","author":"Pantano","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2024.116084_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jat\/bkaa024","article-title":"Detection of drugs in oral fluid samples using a commercially available collection device: agreement with urine testing and evaluation of A and B samples obtained from employees at different workplace settings with uncontrolled sampling procedures","volume":"44","author":"Zheng","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jat\/bkac031","article-title":"Rapid extraction and qualitative screening of 30 drugs in oral fluid at concentrations recommended for the investigation of DUID","volume":"46","author":"Coulter","year":"2022","journal-title":"cases. J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jat\/bkab114","article-title":"Rethinking drug analysis in health care: high-throughput analysis of 71 drugs of abuse in oral fluid using ion mobility--high-resolution mass spectrometry","volume":"46","author":"Bergstr\u00f6m","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib17","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/jat\/bkad051","article-title":"Implementation of the first comprehensive state oral fluid drug testing program for roadside screening and laboratory testing in DUID cases-A 5-year review","volume":"47","author":"Harper","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/jat\/bkad060","article-title":"Towards adherence monitoring using breath or oral fluid as a matrix in a methadone maintenance treatment program for patients with a chronic heroin use disorder: Issues and interpretation of the results","volume":"47","author":"de Jong","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib19","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1515\/cclm-2023-0343","article-title":"Recent advances of drugs monitoring in oral fluid and comparison with blood","volume":"61","author":"Casati","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2024.116084_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.forsciint.2004.10.026","article-title":"Review: The physiology of saliva and transfer of drugs into saliva","volume":"150","author":"Aps","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116084_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116084_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-021-00596-5","article-title":"Alternative matrices in forensic toxicology: a critical review","volume":"40","author":"de Campos","year":"2022","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123824","article-title":"Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid","volume":"1228","author":"Lo Faro","year":"2023","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116084_bib24","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.3390\/ijms24119387","article-title":"GC-MS\/MS Determination of synthetic cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in oral fluid and sweat of consumers under controlled administration: pilot study","volume":"24","author":"Nu\u00f1ez-Montero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2024.116084_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.122966","article-title":"Analysis of drugs including illicit and new psychoactive substances in oral fluids by gas chromatography-drift tube ion mobility spectrometry","volume":"238","author":"Denia","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116084_bib26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/1556-4029.15067","article-title":"Oral fluid analysis to monitor recent exposure to synthetic cannabinoids in a high-risk subpopulation","volume":"67","author":"Pascali","year":"2022","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2024.116084_bib27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2174\/1381612828666220517160545","article-title":"Trends in the pharmaceutical design of new psychoactive substances detected in oral fluid of drivers around a music festival in south-west france: comparison 2019\/2017","volume":"28","author":"Gish","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2024.116084_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jat\/bkaa089","article-title":"Screening of 104 new psychoactive substances (NPS) and other drugs of abuse in oral fluid by LC-MS-MS","volume":"44","author":"da Cunha","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.talanta.2019.04.057","article-title":"Novel sample-substrates for the determination of new psychoactive substances in oral fluid by desorption electrospray ionization-high resolution mass spectrometry","volume":"202","author":"Bianchi","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116084_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2008.09.016","article-title":"ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007","volume":"182","author":"Ventura","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116084_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jat\/bkz114","article-title":"Stability and degradation pathways of different psychoactive drugs in neat and in buffered oral fluid","volume":"44","author":"Marchei","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116084_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.forsciint.2007.06.022","article-title":"HAIRVEQ 2006: evolution of laboratories' performance after different educational actions","volume":"176","author":"Ventura","year":"2008","journal-title":"Forensic Sci. Int."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T20:04:51Z","timestamp":1715285091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S0731708524001249"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116084","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NPS\u2013EQA PART I: Four years\u2019 experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in oral fluid","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116084"}}